BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2022 7:20:14 AM | Browse: 711 | Download: 1921
Publication Name World Journal of Clinical Cases
Manuscript ID 80565
Country China
Received
2022-10-07 16:01
Peer-Review Started
2022-10-07 16:03
First Decision by Editorial Office Director
2022-10-27 00:53
Return for Revision
2022-10-27 00:53
Revised
2022-11-10 03:24
Publication Fee Transferred
Editorial Processing by Scientific Editor
2022-11-24 03:06
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2022-11-24 06:44
Articles in Press
2022-11-24 06:44
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-11-30 15:55
Publish the Manuscript Online
2022-12-14 07:20
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemical Research Methods
Manuscript Type Case Report
Article Title Systemic combined with intravitreal methotrexate for relentless placoid chorioretinitis: A case report
Manuscript Source Unsolicited Manuscript
All Author List Lan Luo, Wei-Bin Chen, Ming-Wei Zhao and Heng Miao
ORCID
Author(s) ORCID Number
Lan Luo http://orcid.org/0000-0002-5325-8000
Wei-Bin Chen http://orcid.org/0000-0003-1152-0960
Ming-Wei Zhao http://orcid.org/0000-0002-8056-9496
Heng Miao http://orcid.org/0000-0003-2510-5848
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China (General Program) 81800847
the tenth "Academic Star" of Peking University People's Hospital RS2018-05
Corresponding Author Heng Miao, MD, Doctor, Doctor, Department of Ophthalmology & Clinical Center of Optometry, Peking University People’s Hospital, Xizhimen South Street 11, Xi Cheng District, Beijing 100044, China. sawyer_young@sina.com
Key Words Immunosuppression; Intravitreal; Methotrexate; Relentless placoid chorioretinitis; Systemic; Case report
Core Tip Relentless placoid chorioretinitis is a bilateral disease in nature and refractory to corticosteroid monotherapy, which warrants the importance of systemic immunosuppressants given upon diagnosis. Intravitreal methotrexate should also be considered as part of the initial therapy for macula-threatening cases in order to halt progression immediately and preserve visual function.
Publish Date 2022-12-14 07:20
Citation Luo L, Chen WB, Zhao MW, Miao H. Systemic combined with intravitreal methotrexate for relentless placoid chorioretinitis: A case report. World J Clin Cases 2022; 10(35): 13115-13121
URL https://www.wjgnet.com/2307-8960/full/v10/i35/13115.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i35.13115
Full Article (PDF) WJCC-10-13115.pdf
Full Article (Word) WJCC-10-13115.docx